Risk factors of inability to live independently in the course of lung cancer

[1] Cho YJ, Cho YM, Kim SH, Shin KH, Jung ST, Kim HS. Clinical analysis of patients with skeletal metastasis of lung cancer. BMC Cancer. 2019; 19: 303. ChoYJ ChoYM KimSH ShinKH JungST KimHS Clinical analysis of patients with skeletal metastasis of lung cancer BMC Cancer. 2019 19 303 10.1186/s12885-019-5534-3644627830943924 Search in Google Scholar

[2] Lee SH. Chemotherapy for lung cancer in the era of personalized medicine. Tuberc Respir Dis. 2019; 82: 179–189. LeeSH Chemotherapy for lung cancer in the era of personalized medicine Tuberc Respir Dis. 2019 82 179 189 10.4046/trd.2018.0068660952330841023 Search in Google Scholar

[3] Shahedah KK, How SH, Jamalludin AR, Mohd Faiz MT, Kuan YC, Ong CK. Depressive symptoms in newly diagnosed lung carcinoma: Prevalence and associated risk factors. Tuberc Respir Dis. 2019; 82: 217–226. ShahedahKK HowSH JamalludinAR Mohd FaizMT KuanYC OngCK Depressive symptoms in newly diagnosed lung carcinoma: Prevalence and associated risk factors Tuberc Respir Dis. 2019 82 217 226 10.4046/trd.2018.0048660952430841021 Search in Google Scholar

[4] Arrieta O, Lopez-Meija M, Macedo-Perez EO, Corona-Cruz JF. Proposals for the prevention of lung Cancer in the Health system of Mexico. Salud Publica de Mexico. 2016; 58: 274–278. ArrietaO Lopez-MeijaM Macedo-PerezEO Corona-CruzJF Proposals for the prevention of lung Cancer in the Health system of Mexico Salud Publica de Mexico. 2016 58 274 278 10.21149/spm.v58i2.779627557385 Search in Google Scholar

[5] Ge T, Lin T, Yang J, Wang M. Nutritional status and related factors of patients with advanced lung cancer in northern China: A retrospective study. Cancer Management and Research. 2019; 11: 2225–2231. GeT LinT YangJ WangM Nutritional status and related factors of patients with advanced lung cancer in northern China: A retrospective study Cancer Management and Research. 2019 11 2225 2231 10.2147/CMAR.S193567643310930962711 Search in Google Scholar

[6] Luo Q, Steinberg J, O'Connel DL, Yu XQ, Caruana M, Wade S, Pesola F, Grogan PB, Dessaix A, Freeman B, et al. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer. 2019; 130: 208–215. LuoQ SteinbergJ O'ConnelDL YuXQ CaruanaM WadeS PesolaF GroganPB DessaixA FreemanB Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer. 2019 130 208 215 10.1016/j.lungcan.2019.02.02830885346 Search in Google Scholar

[7] Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, Salehiniya H, Makhsosi BR, Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Dis. 2016; 8: 1094–1102. RafiemaneshH MehtarpourM KhaniF HesamiSM ShamlouR TowhidiF SalehiniyaH MakhsosiBR MoiniA Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world J Thorac Dis. 2016 8 1094 1102 10.21037/jtd.2016.03.91488602027293825 Search in Google Scholar

[8] Dement JM, Ringen K, Hines S, Cranford K, Quinn PS. Lung cancer mortality among construction workers: Implications for early detection. Occup Environ Med. 2020; 77: 207–213. DementJM RingenK HinesS CranfordK QuinnPS Lung cancer mortality among construction workers: Implications for early detection Occup Environ Med. 2020 77 207 213 10.1136/oemed-2019-10619631996473 Search in Google Scholar

[9] Welch LS, Dement JM, Cranford K, Shorter J, Quinn PS, Madtes DK, Ringen K. Early detection of lung cancer in a population at high risk due to occupation and smoking. Occup Environ Med. 2019; 76: 137–142. WelchLS DementJM CranfordK ShorterJ QuinnPS MadtesDK RingenK Early detection of lung cancer in a population at high risk due to occupation and smoking Occup Environ Med. 2019 76 137 142 10.1136/oemed-2018-10543130415231 Search in Google Scholar

[10] Lehto RH. Symptom burden in lung cancer: Management updates. Lung Cancer Manag. 2016; 5: 61–78. LehtoRH Symptom burden in lung cancer: Management updates Lung Cancer Manag. 2016 5 61 78 10.2217/lmt-2016-0001631030030643551 Search in Google Scholar

[11] Leppert W, Zajaczkowska R, Wordliczek J, Dobrogowski J, Woron J, Krzakowski M. Pathophysiology and clinical characteristics of pain in most common locations in Cancer patients. J Physiol Pharmacol. 2016; 67: 787–799. LeppertW ZajaczkowskaR WordliczekJ DobrogowskiJ WoronJ KrzakowskiM Pathophysiology and clinical characteristics of pain in most common locations in Cancer patients J Physiol Pharmacol. 2016 67 787 799 Search in Google Scholar

[12] Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily diary study of hope, stigma and functioning in lung cancer patients. Health Psychol. 2018; 37: 218–227. SteffenLE VowlesKE SmithBW GanGN EdelmanMJ Daily diary study of hope, stigma and functioning in lung cancer patients Health Psychol. 2018 37 218 227 10.1037/hea0000570583791829172604 Search in Google Scholar

[13] Zahir ST, Mirtalebi M. Survival of patients with lung cancer, Yazd, Iran. Asian Pacific J Cancer Prev. 2012; 13: 4387–4391. ZahirST MirtalebiM Survival of patients with lung cancer, Yazd, Iran Asian Pacific J Cancer Prev. 2012 13 4387 4391 10.7314/APJCP.2012.13.9.4387 Search in Google Scholar

[14] Huang X, Yan A, Liu Q, Liu Q, Wu L. Effects of magnanimous therapy on coping, adjustment and living function in advanced lung cancer. Curr Oncol. 2019; 26: e48–e56. HuangX YanA LiuQ LiuQ WuL Effects of magnanimous therapy on coping, adjustment and living function in advanced lung cancer Curr Oncol. 2019 26 e48 e56 10.3747/co.26.4126638063730853809 Search in Google Scholar

[15] Jazinizade M, Malakoutikhah A, Madadimahani A, Iranmanesh MH, Oghabian S, Mohammadshahi F, Janfaza F, Zakeri MA. Stress and quality of life of patients with cancer: the mediating role of mindfulness. J Oncol. 2020; 2020: 3289521. JazinizadeM MalakoutikhahA MadadimahaniA IranmaneshMH OghabianS MohammadshahiF JanfazaF ZakeriMA Stress and quality of life of patients with cancer: the mediating role of mindfulness J Oncol. 2020 2020 3289521 10.1155/2020/3289521774889533381176 Search in Google Scholar

[16] Lehto RH. Psychosocial challenges for patients with advanced lung cancer: Interventions to improve well-being. Lung Cancer Targets and Therapy. 2017; 8: 79–90. LehtoRH Psychosocial challenges for patients with advanced lung cancer: Interventions to improve well-being Lung Cancer Targets and Therapy. 2017 8 79 90 10.2147/LCTT.S120215554682728814906 Search in Google Scholar

[17] Oancea C, Suciu C, Timar B, Papava I, Raica M, Burlacu O. The reciprocal relationship between coping mechanisms and lung cancer diagnosis: Findings of a prospective study. Cancer Management and Research. 2018; 10: 33–40. OanceaC SuciuC TimarB PapavaI RaicaM BurlacuO The reciprocal relationship between coping mechanisms and lung cancer diagnosis: Findings of a prospective study Cancer Management and Research. 2018 10 33 40 10.2147/CMAR.S148341575748929379318 Search in Google Scholar

[18] Abazari M, Gholamnejad M, Roshanaei G, Abazari R, Roosta Y, Mahjub M. Estimation of survival rates in patients with lung cancer in West Azerbaijan, the Northwest of Iran. Asian Pacific J Cancer Prev. 2015; 16: 3923–3926. AbazariM GholamnejadM RoshanaeiG AbazariR RoostaY MahjubM Estimation of survival rates in patients with lung cancer in West Azerbaijan, the Northwest of Iran Asian Pacific J Cancer Prev. 2015 16 3923 3926 10.7314/APJCP.2015.16.9.3923 Search in Google Scholar

[19] Abedi S, Janbabaei G, Afshari M, Moosazadeh M, Rashidi Alashti M, Hedayatizadeh-Omran A, Alizadeh-Navaei R, Abedini E. Estimating the survival of patients with lung cancer: what is the best statistical model? J Prev Med Public Health. 2019; 52: 140–144. AbediS JanbabaeiG AfshariM MoosazadehM Rashidi AlashtiM Hedayatizadeh-OmranA Alizadeh-NavaeiR AbediniE Estimating the survival of patients with lung cancer: what is the best statistical model? J Prev Med Public Health. 2019 52 140 144 10.3961/jpmph.17.090645976030971081 Search in Google Scholar

[20] Hellmann MD, Li BT, Chaft JE, Kris MG. Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol. 2016; 27: 1829–1835. HellmannMD LiBT ChaftJE KrisMG Chemotherapy remains an essential element of personalized care for persons with lung cancers Ann Oncol. 2016 27 1829 1835 10.1093/annonc/mdw271503578627456296 Search in Google Scholar

[21] Chabowski M, Polanski J, Jankowska-Polanska B, Lomper K, Janczak D, Rosinczuk J. The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer. J Thorac Dis. 2017; 9: 2952–2958. ChabowskiM PolanskiJ Jankowska-PolanskaB LomperK JanczakD RosinczukJ The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer J Thorac Dis. 2017 9 2952 2958 10.21037/jtd.2017.08.70570845329221267 Search in Google Scholar

[22] Gu W, Xu YM, Zhu JH, Zhong BL. Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer. Oncotarget. 2017; 8: 104806–12. GuW XuYM ZhuJH ZhongBL Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer Oncotarget. 2017 8 104806 12 10.18632/oncotarget.21001573960229285215 Search in Google Scholar

[23] Udupa K, Rajendranath R, Sagar TG. Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy. Indian J Cancer. 2017; 54: 161–163. UdupaK RajendranathR SagarTG Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy Indian J Cancer. 2017 54 161 163 10.4103/0019-509X.21955829199681 Search in Google Scholar

[24] Yun YH, Kim YA, Sim JA, Shin AS, Chang YJ, Lee J, Kim MS, Shim YM, Zo JL. Prognostic value of quality of life score in disease-free survivors of surgically treated lung cancer. BMC Cancer. 2016; 16: 505. YunYH KimYA SimJA ShinAS ChangYJ LeeJ KimMS ShimYM ZoJL Prognostic value of quality of life score in disease-free survivors of surgically treated lung cancer BMC Cancer. 2016 16 505 10.1186/s12885-016-2504-x495205827439430 Search in Google Scholar

[25] Wilmowska-Pietruszyńska A. Health, financial and social situation of the disabled and the dependent in Poland. Orzecznictwo Lekarskie. 2009; 6: 1–12. Wilmowska-PietruszyńskaA Health, financial and social situation of the disabled and the dependent in Poland Orzecznictwo Lekarskie. 2009 6 1 12 Search in Google Scholar

[26] Wilmowska-Pietruszyńska A. Social security for the disabled and the dependent in Poland. Orzecznictwo Lekarskie. 2007; 4: 13–25. Wilmowska-PietruszyńskaA Social security for the disabled and the dependent in Poland Orzecznictwo Lekarskie. 2007 4 13 25 Search in Google Scholar

[27] Wilmowska-Pietruszyńska A. The risk of incapacity for independent living-necessity of social protection. Polityka Zdrowotna. 2012; 10: 41–55. Wilmowska-PietruszyńskaA The risk of incapacity for independent living-necessity of social protection Polityka Zdrowotna. 2012 10 41 55 Search in Google Scholar

[28] Giuliani ME, Milne RA, Puts M, Sampson LR, Kwan JYY, Le LW, Alibhai SMH, Howell D, Abdelmutti N, Liu G, et al. The prevalence and nature of supportive care needs in lung cancer patients. Curr Oncol. 2016; 23: 258–265. GiulianiME MilneRA PutsM SampsonLR KwanJYY LeLW AlibhaiSMH HowellD AbdelmuttiN LiuG The prevalence and nature of supportive care needs in lung cancer patients Curr Oncol. 2016 23 258 265 10.3747/co.23.3012497403327536176 Search in Google Scholar

[29] Tradecki M, Ziółkowska J, Roemer-Ślimak R, Mazur G, Butrym A. Inability to live independently in the course of breast cancer: Main risk factors. Pol Arch Intern Med. 2021; 131: 16118. TradeckiM ZiółkowskaJ Roemer-ŚlimakR MazurG ButrymA Inability to live independently in the course of breast cancer: Main risk factors Pol Arch Intern Med. 2021 131 16118 Search in Google Scholar

[30] Mahoney FI, Barthel DQ. Functional evaluation: The Barthel Index. Md State Med. J. 1965; 14: 61–65. MahoneyFI BarthelDQ Functional evaluation: The Barthel Index Md State Med. J. 1965 14 61 65 Search in Google Scholar

[31] Lundin A, Driscoll B. Lung cancer stem cells: progress and prospects. Cancer Lett. 2013; 338: 89–93. LundinA DriscollB Lung cancer stem cells: progress and prospects Cancer Lett. 2013 338 89 93 10.1016/j.canlet.2012.08.014368699622906416 Search in Google Scholar

[32] Lim RBL. End-of-life care in patients with advanced lung cancer. Adv Respir Dis. 2016; 10: 455–467. LimRBL End-of-life care in patients with advanced lung cancer Adv Respir Dis. 2016 10 455 467 10.1177/1753465816660925593361927585597 Search in Google Scholar